[Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].
Facteurs prédictifs de l’ostéoradionécrose mandibulaire après irradiation des cancers des voies aérodigestives supérieures.
Bone Density Conservation Agents
/ therapeutic use
Clodronic Acid
/ therapeutic use
Drug Therapy, Combination
Head and Neck Neoplasms
/ radiotherapy
Humans
Hyperbaric Oxygenation
Mandibular Diseases
/ etiology
Osteoradionecrosis
/ classification
Pentoxifylline
/ therapeutic use
Radiotherapy Dosage
Risk Factors
Tocopherols
/ therapeutic use
Cancers VADS
Dosimetric parameters
Dosimétrie
Facteurs prédictifs
Head and neck cancers
Mandibular osteoradionecrosis
Ostéoradionécrose mandibulaire
Predictive factors
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
23
09
2020
revised:
05
03
2021
accepted:
18
03
2021
pubmed:
11
4
2021
medline:
20
7
2021
entrez:
10
4
2021
Statut:
ppublish
Résumé
The identification of the different risk factors for mandibular osteoradionecrosis (ORN) must be done before and after the management of patients with head and neck cancer. Various clinical criteria for this severe radiation-induced complication are related to the patient (intrinsic radiosensitivity, malnutrition associated with thin weight loss, active smoking intoxication, microcapillary involvement, precarious oral status, hyposalivation) and/or related to the disease (oral cavity, large tumor size, tumor mandibular invasion). Therapeutic risk factors are also associated with a higher risk of ORN (primary tumor surgery, concomitant radio-chemotherapy, post-irradiation dental avulsion, preventive non-observance with the absence of stomatological follow-up and daily installation of gutters fluoride and, non-observance curative healing treatments). Finally, various dosimetric studies have specified the parameters in order to target the dose values distributed in the mandible, which increases the risk of ORN. An mean mandibular dose greater than 48-54Gy and high percentages of mandibular volume receiving 40 to 60Gy appear to be discriminating in the risk of developing an ORN.
Identifiants
pubmed: 33836955
pii: S1278-3218(21)00049-4
doi: 10.1016/j.canrad.2021.03.002
pii:
doi:
Substances chimiques
Bone Density Conservation Agents
0
Clodronic Acid
0813BZ6866
Tocopherols
R0ZB2556P8
Pentoxifylline
SD6QCT3TSU
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
484-493Informations de copyright
Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.